Medicare Enrolled
Dr. Silvio Quaglia, M.D.
Adolescent Medicine · Millburn, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quaglia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quaglia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quaglia
Dr. Silvio Quaglia is an adolescent medicine specialist in Millburn, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Quaglia performed 2,096 Medicare services across 1,141 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quaglia received a total of $128,271 from 77 pharmaceutical and/or device companies across 1406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in adolescent medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quaglia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 44% volume in NJ
$128,271 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,096
Medicare services
Top 44% in NJ for adolescent medicine
1,141
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~100 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,093 | $139 | $260 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
128 | $34 | $42 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
125 | $11 | $32 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
91 | $76 | $78 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
80 | $12 | $47 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
71 | $12 | $60 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
70 | $34 | $42 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
68 | $281 | $330 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
63 | $142 | $208 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $91 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $61 | $130 |
| Respiratory syncytial virus (RSV) nucleic acid test A laboratory test that uses nucleic acid amplification to detect the presence of respiratory syncytial virus in a sample. |
35 | $69 | $100 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
31 | $42 | $110 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
30 | $72 | $76 |
| Annual alcohol misuse screening, 5 to 15 minutes | 29 | $21 | $35 |
| Substance misuse assessment and brief intervention A structured assessment of alcohol or substance misuse combined with a brief intervention lasting 15 to 30 minutes. |
25 | $28 | $62 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
19 | $128 | $135 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
18 | $42 | $43 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
17 | $37 | $89 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
16 | $50 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$128,271
Total received (2018-2024)
Avg $18,324/year across 7 years
Top 5% in NJ for adolescent medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
1,406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109,924 (85.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,832 (10.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,515 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,537
2023
$7,351
2022
$7,676
2021
$26,975
2020
$15,411
2019
$40,287
2018
$29,034
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$234
Amgen Inc.
$224
AstraZeneca Pharmaceuticals LP
$180
Novo Nordisk Inc
$171
GlaxoSmithKline, LLC.
$135
Bayer Healthcare Pharmaceuticals Inc.
$88
PFIZER INC.
$80
Esperion Therapeutics, Inc.
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Exact Sciences Corporation
$76
Azurity Pharmaceuticals, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
QIAGEN, LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Lilly USA, LLC
$16
Almatica Pharma LLC
$16
Lundbeck LLC
$16
Otsuka America Pharmaceutical, Inc.
$15
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$39,862
Genentech USA, Inc.
$37,283
Amgen Inc.
$16,906
IDORSIA PHARMACEUTICALS US INC
$6,056
AbbVie Inc.
$6,004
ABBVIE INC.
$4,507
Celgene Corporation
$3,636
Novo Nordisk Inc
$1,309
Kowa Pharmaceuticals America, Inc.
$1,125
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,054
PFIZER INC.
$924
AstraZeneca Pharmaceuticals LP
$916
Allergan, Inc.
$904
Shire North American Group Inc
$893
GlaxoSmithKline, LLC.
$748
ARBOR PHARMACEUTICALS, INC.
$723
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$600
Amarin Pharma Inc.
$596
SANOFI-AVENTIS U.S. LLC
$449
Merck Sharp & Dohme Corporation
$352
Otsuka America Pharmaceutical, Inc.
$341
Lilly USA, LLC
$311
IBSA Pharma Inc.
$276
Novartis Pharmaceuticals Corporation
$174
Bayer Healthcare Pharmaceuticals Inc.
$172
Teva Pharmaceuticals USA, Inc.
$159
Eisai Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$117
Exact Sciences Corporation
$100
Gilead Sciences, Inc.
$96
Collegium Pharmaceutical, Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$87
Horizon Pharma plc
$81
Esperion Therapeutics, Inc.
$79
Purdue Pharma L.P.
$72
Biohaven Pharmaceuticals, Inc.
$70
DEXCOM, INC.
$70
Azurity Pharmaceuticals, Inc.
$69
Supernus Pharmaceuticals, Inc.
$63
Almatica Pharma LLC
$56
Alexion Pharmaceuticals, Inc.
$56
Horizon Therapeutics plc
$48
SCILEX PHARMACEUTICALS INC.
$42
Scilex Pharmaceuticals Inc.
$41
Zyla Life Sciences
$40
Daiichi Sankyo Inc.
$40
Bausch Health US, LLC
$38
Dynavax Technologies Corporation
$37
Sunovion Pharmaceuticals Inc.
$28
BioDelivery Sciences International, Inc.
$27
Medicure Pharma Inc.
$26
Astellas Pharma US Inc
$25
Dexcom, Inc.
$22
Hikma Pharmaceuticals USA
$21
Abbott Laboratories
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$18
QIAGEN, LLC
$18
Incyte Corporation
$17
VBI Vaccines (Delaware) Inc.
$17
Lundbeck LLC
$16
Promius Pharma LLC
$15
SANOFI PASTEUR INC.
$15
INTRA-SANA LABORATORIES
$15
Xeris Pharmaceuticals, Inc.
$15
KADMON PHARMACEUTICALS LLC
$15
Zyla Life Sciences, Inc.
$15
PROTEGA PHARMACEUTIALS LLC
$14
EISAI INC.
$14
ANI Pharmaceuticals, Inc.
$14
Seqirus USA Inc
$13
Alfasigma USA, Inc.
$13
Althera Pharmaceuticals LLC
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
Iroko Pharmaceuticals, LLC
$12
Ironwood Pharmaceuticals, Inc
$12
Aytu BioScience, Inc
$11
Allergan Inc.
$11
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AIMOVIG · AIRSUPRA · AJOVY · ANORO ELLIPTA · APLENZIN · AREXVY · Aimovig · Amitiza · BELBUCA · BELSOMRA · BEXSERO · BREATHTEK · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAPLYTA · CHANTIX · CITALOPRAM · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUEXIS · DUZALLO · Dayvigo · Dexcom G6 Transmitter · EDARBYCLOR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · Fluad · GEMTESA · GLYXAMBI · GVOKE PFS · HORIZANT · Heplisav-B · Horizant · INVOKAMET · INVOKANA · InderalXL · JANUVIA · JARDIANCE · Kerendia · Kloxxado · LEQVIO · LINZESS · LIVALO · LOREEV XR · LUCEMYRA · LYRICA · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Morphabond ER · NEXLETOL · NURTEC ODT · Natesto · OFEV · OPZELURA · Otezla · Otovel · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Roszet · Roxybond · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Seglentis · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULANCE · TRULICITY · TRUMENBA · TZIELD · Tirosint · Tresiba · Trintellix · UBRELVY · Uloric · VIBERZI · VIIBRYD · VIMOVO · VIVLODEX · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · ZYPITAMAG · ZYPITAMAG (pitavastatin) · Zelnorm · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in adolescent medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for adolescent medicine in NJ.
Geographic Context
Adolescent medicines within 10 mi
24
Per 100K population
2.8
County median income
$76,712
Nearest hospital
OVERLOOK MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quaglia is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NJ peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quaglia experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Quaglia performed 1,093 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quaglia receive payments from pharmaceutical companies?
Yes. Dr. Quaglia received a total of $128,271 from 77 companies across 1,406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quaglia's costs compare to other adolescent medicines in Millburn?
Dr. Quaglia's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quaglia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adolescent Medicines in Millburn
Browse adolescent medicines in Millburn ranked by procedure volume and transparency data.
Highest volume
Top Adolescent Medicines in NJ
Adolescent medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adolescent Medicines in NJ
Which NJ adolescent medicines receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology